Top 20 biopharmas’ market cap rises 6% in Q1 2025 amid tariff headwinds
The top 20 biopharmaceutical companies demonstrated a strong start to 2025, despite ongoing uncertainty surrounding the potential impact of President…
Analyst Comment
Synthetic hormones and the future of contraception
First two medicinal products to undergo EU joint clinical assessments announced
The 7MM atopic dermatitis market to experience growth, reaching $22.4bn by 2033
Do in vivo CAR-T cell therapies have the potential to overtake ex vivo CAR-Ts?
ESCMID Global 2025: Climate-informed infectious disease risk management
COPD market projected to grow to $30.2bn in the 7MM by 2033
AAN 2025: Long-term outcome data on steroid regimens in MG may guide treatment standards
